Cargando…
Immunotherapy for Dogs: Running Behind Humans
A number of excellent reviews on the potential of canine cancer immunotherapy are available, but many extrapolate from observations in humans when in fact only very few immunotherapies have been developed for canines that have shown efficacy in well-designed studies. Pharmaceutical and biotech compa...
Autor principal: | Klingemann, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807660/ https://www.ncbi.nlm.nih.gov/pubmed/29459862 http://dx.doi.org/10.3389/fimmu.2018.00133 |
Ejemplares similares
-
Immunotherapy for Dogs: Still Running Behind Humans
por: Klingemann, Hans
Publicado: (2021) -
Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016) -
Cellular Immunotherapy of Canine Cancer
por: Addissie, Selamawit, et al.
Publicado: (2018) -
A Role for Dogs in Advancing Cancer Immunotherapy Research
por: Dow, Steven
Publicado: (2020) -
P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)